Defining the path: lung cancer CT screening in Europe

Affiliations

¹ Department of Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
² Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.

Editorial

Matthew E Callister et al. Thorax. 2017 Sep.

. 2017 Sep;72(9):778-779.

doi: 10.1136/thoraxjnl-2017-210268. Epub 2017 Jul 19.

¹ Department of Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
² Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.

No abstract available

Keywords: Lung Cancer.

Conflict of interest statement

Competing interests: None declared.

Risk stratification based on screening history: the NELSON lung cancer screening study.
Yousaf-Khan U, van der Aalst C, de Jong PA, Heuvelmans M, Scholten E, Walter J, Nackaerts K, Groen H, Vliegenthart R, Ten Haaf K, Oudkerk M, de Koning H. Yousaf-Khan U, et al. Thorax. 2017 Sep;72(9):819-824. doi: 10.1136/thoraxjnl-2016-209892. Epub 2017 Mar 30. Thorax. 2017. PMID: 28360223 Clinical Trial.
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.
Paci E, Puliti D, Lopes Pegna A, Carrozzi L, Picozzi G, Falaschi F, Pistelli F, Aquilini F, Ocello C, Zappa M, Carozzi FM, Mascalchi M; the ITALUNG Working Group. Paci E, et al. Thorax. 2017 Sep;72(9):825-831. doi: 10.1136/thoraxjnl-2016-209825. Epub 2017 Apr 4. Thorax. 2017. PMID: 28377492 Clinical Trial.